Navigation Links
Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
Date:10/23/2008

Details to be presented at NACFC and ICAAC/IDSA meetings this week

SAN DIEGO, Oct. 23 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that aerosol dosing of MP-376 was well tolerated at all dose levels tested after 14 days of dosing. Encouraging signs of drug activity were also observed in this trial. New preclinical results demonstrate that MP-376 has potent activity against Pseudomonas aeruginosa (P. aeruginosa) infection under a wide array of conditions, avoids resistance development when used at high concentrations achievable with aerosol dosing and has anti-inflammatory properties in pulmonary tissues in addition and unrelated to its antibacterial effects. Detailed results are being presented at the North American Cystic Fibrosis Conference (NACFC) and ICAAC/IDSA meetings taking place this week in Orlando, Florida and Washington, D.C., respectively.

Clinical Results

The clinical results being presented at NACFC are from a Phase 1b safety, tolerability and pharmacokinetic (PK) study performed in 40 CF patients with stable disease at 11 U.S. clinical sites (Mpex 203). The study was a placebo-controlled, dose escalation trial to analyze the effects of 14 days of dosing at three different dose levels of MP-376 when administered by inhalation using an Investigational eFlow Nebulizer System.

All patients were required to be culture positive for P. aeruginosa at baseline. P. aeruginosa is a bacterial pathogen that is a leading cause of morbidity in CF patients. The great majority of CF patients over the age of 18 are chronically infected with this pathogen and chronic infection has been shown to lead to acute exacerbations and subsequent loss of l
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
2. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
3. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
4. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Critical Pharmaceuticals Enter Sustained Release hGH Arena
11. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
(Date:3/3/2015)... , March 3, 2015  Michigan brothers Dominique ... condition called arrhythmogenic right ventricular dysplasia, or ARVD, a disease ... of sudden death among young athletes. In 2007, ... a basketball game. They later tested Dominique and found his ... a February 19, 2015 story in The Ann Arbor ...
(Date:3/3/2015)... , March 3, 2015  Web Industries, ... manufacturing services in the Medical Device, Advanced Composites, ... been named a 3M Medical Specialties Preferred Converter ... status will allow companies to streamline their supply ... of contact for 3M materials, intermediate converting services, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Web Industries Receives 3M Preferred Converter Status 2
(Date:3/3/2015)... On February 24, 2015, a Toledo, ... States District Court for the Northern District of Ohio ... as insurance companies Balboa, QBE, and Newport Management. (See ... 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, says ... her to buy too much insurance at rates that ...
(Date:3/3/2015)... 2015 Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... atypical antipsychotic medication continue to move forward in ... the South Carolina Supreme Court upheld a state ... Janssen Pharmaceuticals unit had deceptively marketed the medication ... Court’s February 25th decision characterized the company’s conduct ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 Loma ... to whole health and well being, it will be ... machines across its campuses. , Over the past year, ... took part in creating dietary criteria, listening to vendors, ... for the entire organization. , Most recently, a ...
(Date:3/3/2015)... Today, Steve Weatherford, current New York Giants punter, ... the donation of their brains to science during a ... In an effort to raise awareness for the impact ... Rice and Weatherford spoke of their experiences on and ... health a priority to avoid the consequences of injuries ...
(Date:3/3/2015)... 03, 2015 Man, Woman & Student ... help find cures and ensure access to treatments for ... for patents and their families. Through this annual national ... the fight for a world without blood cancers. The ... in the country, to be announced this summer. To ...
Breaking Medicine News(10 mins):Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3
... , ZURICH , Jan. 25 The Starr ... to two humanitarian organizations providing critical relief in Haiti . ... support efforts to deliver much-needed medical care, clean water and sanitation ... $750,000 grant to Partners in Health (PIH) to help ...
... , , WASHINGTON ... an unsafe, counterfeit version of the weight-loss drug Alli sold over ... tests showed that the counterfeit Alli has a different active ingredient, ... counterfeit Alli may be taking three times the usual ...
... shows that acyclovir, a commonly prescribed drug used to suppress ... by people with both viruses. The study, conducted ... by the New England Journal of Medicine in ... print edition Feb. 4. The largest risk group ...
... ... Orange Israel Telecommunications have announced today that they are aiding humanitarian efforts in ... be the first of three stages of establishing the orphanage which is expected ... be providing fresh, running drinking water, an electric generator, tents and primary medical ...
... WASHINGTON , Jan. 25 In an effort ... is currently accepting applications for its 2010 Advocates in Disability Award, ... 26 in the Washington, DC Metropolitan area who is ... on their current and previous work that impacts people with disabilities, ...
... , NEW YORK , ... of the 25 largest PR firms ( http://www.5wpr.net/ ) in the U.S., today ... its versatile roster of fashion and lifestyle clients. Launched in 2002, the luxury ... lifestyle products using proprietary natural frequency technology. , " Philip Stein is ...
Cached Medicine News:Health News:Starr International Foundation Gives $1 Million To Earthquake Relief Effort In Haiti 2Health News:FDA CONSUMER HEALTH INFORMATION: FDA Warns Consumers About Unsafe Counterfeit Alli 2Health News:Control of herpes symptoms does not reduce HIV transmission, international study found 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 3Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 4Health News:DC Nonprofit Searches for Next Generation of Disability Advocates 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 3
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
... in both neonatal and pediatric sizes., ,The ... it has a cuff. When completely deflated, it ... , ,TTS™ (tight-to-shaft) tubes have the profile ... a cuff, if and when needed. , ...
... TTS™ tracheostomy tubes are available in both neonatal ... like an uncuffed tube, but it has a ... the shaft of the tube. , ,TTS™ ... tube with the insurance of a cuff, if ...
... tracheostomy tubes are intended for ... length fixed neck flange tube ... ,Adjustable neck flange Hyperflex™ tracheostomy ... both horizontal and vertical shaft ...
Medicine Products: